1207625-18-0

Basic information

• Product Name: 3-chloro-7H-pyrrolo[2,3-c]pyridazine
• Synonyms: 3-chloro-7H-pyrrolo[2,3-c]pyridazine;7H-Pyrrolo[2,3-c]pyridazine, 3-chloro-;3-Chloro-7H-pyrrolo[2,3-c...
• CAS NO: 1207625-18-0
• Molecular Formula: C₆H₄ClN₃
• Molecular Weight: 153.56906
• Mol File: 1207625-18-0.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Density: 1.531±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 10.63±0.50(Predicted)
• CAS DataBase Reference: 3-chloro-7H-pyrrolo[2,3-c]pyridazine(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-7H-pyrrolo[2,3-c]pyridazine(1207625-18-0)
• EPA Substance Registry System: 3-chloro-7H-pyrrolo[2,3-c]pyridazine(1207625-18-0)

Safety Data

• Hazardous Substances Data: 1207625-18-0(Hazardous Substances Data)

Usage

General Description

3-chloro-7H-pyrrolo[2,3-c]pyridazine is a chemical compound that falls under the category of pyridazines, which are heterocyclic organic compounds having two nitrogen atoms in their ring structure. The exact properties and potential uses of this particular compound are not widely documented in scientific literature as of now. This often indicates that the compound is not commonly used or studied, possibly due to difficulty in synthesis, lack of known practical applications, or potential instability. Like other organic compounds, characteristics such as solubility, reactivity, and melting and boiling points of 3-chloro-7H-pyrrolo[2,3-c]pyridazine would be determined by its molecular structure.

Upstream product

• 1207625-15-7 6-chloro-4-((trimethylsilyl)ethynyl)pyridazin-3-amine 
• 1207625-17-9 6-Chloro-4-(2,2-dimethoxyethyl)pyridazin-3-amine 
• 1207625-16-8 N-Acetyl-N-{6-chloro-4-[(trimethylsilyl)ethynyl]pyridazin-3-yl}acetamide 

Downstream Products

• 1349723-33-6 5-[(2,6-dichloro-3-fluorophenyl)(methoxy)methyl]-3-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-c]pyridazine 

Relevant articles and documents

THIADIAZOLE DERIVATIVE AND USES THEREOF AS A GLS1 INHIBITOR

Disclosed is to a thiadiazole derivative and the uses thereof in preparing a drug for treating GLS1-associated diseases. Specifically disclosed is a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.

SMARCA INHIBITORS AND USES THEREOF

The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are useful in treatment of cancer.

6,7-DIAZAINDAZOLE AND 6,7-DIAZAINDOLE DERIVATIVES AND USE IN TREATMENT, AMELIORATION OR PREVENTION OF INFLUENZA THEREOF

Provided herein is a compound of formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, prodrug, codrug, cocrystal, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which is useful in treating, ameliorating or preventing influenza.